Morgan Stanley
IMNP

Morgan Stanley’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Morgan Stanley’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed – – 6974
2018
Q2 		$0 Sell
3
-2,746
-100% -$777 ﹤0.01% 6862
2018
Q1 		$1K Buy
2,749
+2,695
+4,991% +$1.28K ﹤0.01% 6581
2017
Q4 		$0 Buy
54
+49
+980% +$47 ﹤0.01% 6781
2017
Q3 		$0 Buy
5
+1
+25% +$2 ﹤0.01% 6698
2017
Q2 		$0 Sell
4
-1
-20% -$3 ﹤0.01% 6731
2017
Q1 		$0 Buy
+5
New +$18 ﹤0.01% 6674
2016
Q3 		– Sell
-3
Closed – – 6618
2016
Q2 		$0 Hold
3
– – ﹤0.01% 6789
2016
Q1 		$0 Hold
3
– – ﹤0.01% 6848
2015
Q4 		$0 Buy
+3
New +$63 ﹤0.01% 6916
2015
Q3 		– Sell
-2
Closed – – 6829
2015
Q2 		$0 Hold
2
– – ﹤0.01% 6845
2015
Q1 		$0 Sell
2
-4
-67% -$150 ﹤0.01% 6747
2014
Q4 		$0 Sell
6
-504
-99% -$27.1K ﹤0.01% 6759
2014
Q3 		$35K Buy
+510
New +$36.3K ﹤0.01% 5840

Other funds holding IMNP

IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Morgan Stanley's IMNP Position: Q3 2018 in Review

Morgan Stanley sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 3 shares.

Morgan Stanley first reported a position in IMNP in Q3 2014 and held it in 13 quarters. The position peaked at $35K in Q3 2014. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

  • Morgan Stanley reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Morgan Stanley sold 3 Immune Pharmaceuticals Inc. shares in Q3 2018.
  • Morgan Stanley first reported a position in Immune Pharmaceuticals Inc. in Q3 2014 and held it in 13 quarters.
  • Morgan Stanley's Immune Pharmaceuticals Inc. position peaked at $35K in Q3 2014.
  • 1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.